Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
16 February 2024 - 8:05AM
Business Wire
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the
“Company”) will report its fourth quarter and full year 2023
financial results on Thursday, February 22, 2024. Amylyx’ senior
management team will host a conference call and audio webcast at
8:00 a.m. ET to discuss the financial results and other company
updates.
To access the conference call, please dial +1 (800) 836-8184
(U.S. & Canada) or +1 (646) 357-8785 (international) at least
10 minutes prior to the start time and ask to be joined into the
Amylyx Pharmaceuticals call. A live audio webcast of the call will
be available under “Events and Presentations” in the Investor
section of the Company’s website,
https://investors.amylyx.com/news-events/events. The webcast will
be archived and available for replay for 90 days following the
event.
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is committed to supporting and
creating more moments for the neurodegenerative community through
the discovery and development of innovative new treatments. Amylyx
is headquartered in Cambridge, Massachusetts and has operations in
Canada, EMEA, and Japan. For more information, visit amylyx.com and
follow us on LinkedIn and X, formerly known as Twitter. For
investors, please visit investors.amylyx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240215063314/en/
Media Amylyx Media Team +1 (857) 799-7274
amylyxmediateam@amylyx.com Investors Lindsey Allen Amylyx
Pharmaceuticals, Inc. +1 (857) 320-6244 Investors@amylyx.com
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From Apr 2024 to May 2024
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From May 2023 to May 2024
